FRONTIER CAPITAL MANAGEMENT CO LLC - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 383 filers reported holding NEKTAR THERAPEUTICS in Q2 2018. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.

Quarter-by-quarter ownership
FRONTIER CAPITAL MANAGEMENT CO LLC ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q4 2021$1,497,000
-11.2%
110,820
+18.1%
0.01%
-7.7%
Q3 2021$1,685,000
-16.0%
93,800
-19.7%
0.01%
-13.3%
Q2 2021$2,006,000
-77.5%
116,871
-73.8%
0.02%
-77.6%
Q1 2021$8,918,000
+410.2%
445,922
+333.6%
0.07%
+415.4%
Q4 2020$1,748,000
-87.3%
102,831
-87.6%
0.01%
-89.2%
Q3 2020$13,774,000
-33.6%
830,262
-7.4%
0.12%
-34.8%
Q2 2020$20,755,000
+3.2%
896,172
-20.4%
0.18%
-18.6%
Q1 2020$20,103,000
+39.8%
1,126,206
+69.0%
0.23%
+113.2%
Q4 2019$14,384,000
-0.5%
666,400
-16.1%
0.11%
-6.2%
Q3 2019$14,461,000
-52.9%
793,906
-8.0%
0.11%
-51.3%
Q2 2019$30,710,000
+10.3%
863,129
+4.2%
0.23%
+17.2%
Q1 2019$27,833,000
+6.5%
828,350
+4.1%
0.20%
-6.2%
Q4 2018$26,144,000
-67.0%
795,389
-38.7%
0.21%
-58.6%
Q3 2018$79,144,000
+48.4%
1,298,286
+18.8%
0.51%
+34.9%
Q2 2018$53,342,000
-25.7%
1,092,395
+61.6%
0.38%
-27.7%
Q1 2018$71,838,000676,0580.52%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q2 2018
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 1,828,400$89,281,0006.61%
Cormorant Asset Management, LP 1,500,000$73,245,0005.42%
Camber Capital Management LP 2,000,000$97,660,0003.76%
Rhenman & Partners Asset Management AB 617,652$30,160,0003.09%
BRIDGER MANAGEMENT, LLC 1,134,414$55,393,0003.00%
First Light Asset Management, LLC 374,251$18,275,0002.84%
Gs Investments, Inc. 54,000$2,636,820,0001.97%
SABBY MANAGEMENT, LLC 241,922$11,813,0001.82%
QUANTRES ASSET MANAGEMENT Ltd 50,000$2,441,0001.41%
Tibra Equities Europe Ltd 173,183$8,457,0001.27%
View complete list of NEKTAR THERAPEUTICS shareholders